Essential immunologic orchestrators of intestinal homeostasis

Science Immunology

Volumn 3, Issue 20, 2018, Pages

  Zhou, Lei ^a   Sonnenberg, Gregory F ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ARTICLE; HOST MICROBE INTERACTION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INFLAMMATION; INFLAMMATORY BOWEL DISEASE; INTESTINAL HOMEOSTASIS; INTESTINE FLORA; INTESTINE FUNCTION; MAMMAL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; ANIMAL; HOMEOSTASIS; IMMUNOLOGY; INTESTINE; MICROBIOLOGY; MICROFLORA;

ANIMALS; HOMEOSTASIS; HUMANS; INFLAMMATION; INTESTINES; MICROBIOTA;

EID: 85047955282     PISSN: None     EISSN: 24709468     Source Type: Journal    
DOI: 10.1126/sciimmunol.aao1605     Document Type: Article

References (73)

1. W. S. Garrett, J. I. Gordon, L. H. Glimcher, Homeostasis and inflammation in the intestine. Cell 140, 859–870 (2010).
2. K. Honda, D. R. Littman, The microbiome in infectious disease and inflammation. Annu. Rev. Immunol. 30, 759–795 (2012).
3. L. V. Hooper, D. R. Littman, A. J. Macpherson, Interactions between the microbiota and the immune system. Science 336, 1268–1273 (2012).
4. R. Kühn, J. Löhler, D. Rennick, K. Rajewsky, W. Müller, Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75, 263–274 (1993).
5. P. Mombaerts, E. Mizoguchi, M. J. Grusby, L. H. Glimcher, A. K. Bhan, S. Tonegawa, Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 75, 274–282 (1993).
6. B. Sadlack, H. Merz, H. Schorle, A. Schimpl, A. C. Feller, I. Horak, Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75, 253–261 (1993).
7. K. W. Moore, A. O’Garra, R. de Waal Malefyt, P. Vieira, T. R. Mosmann, Interleukin-10. Annu. Rev. Immunol. 11, 165–190 (1993).
8. S. D. Spencer, F. Di Marco, J. Hooley, S. Pitts-Meek, M. Bauer, A. M. Ryan, B. Sordat, V. C. Gibbs, M. Aguet, The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor. J. Exp. Med. 187, 571–578 (1998).
9. + T cells, but not B cells, mediate colitis in interleukin 10-deficient mice. J. Exp. Med. 184, 241–251 (1996).
10. W. Ouyang, S. Rutz, N. K. Crellin, P. A. Valdez, S. G. Hymowitz, Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu. Rev. Immunol. 29, 71–109 (2011).
11. A. Roers, L. Siewe, E. Strittmatter, M. Deckert, D. Schlüter, W. Stenzel, A. D. Gruber, T. Krieg, K. Rajewsky, W. Müller, T cell–specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation. J. Exp. Med. 200, 1289–1297 (2004).
12. Y. P. Rubtsov, J. P. Rasmussen, E. Y. Chi, J. Fontenot, L. Castelli, X. Ye, P. Treuting, L. Siewe, A. Roers, W. R. Henderson Jr., W. Muller, A. Y. Rudensky, Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28, 546–558 (2008).
13. A. Chaudhry, R. M. Samstein, P. Treuting, Y. Liang, M. C. Pils, J. M. Heinrich, R. S. Jack, F. T. Wunderlich, J. C. Brüning, W. Müller, A. Y. Rudensky, Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. Immunity 34, 566–578 (2011).
14. + T cells in an interleukin-10-dependent manner. Immunity 34, 554–565 (2011).
15. D. S. Shouval, A. Biswas, J. A. Goettel, K. McCann, E. Conaway, N. S. Redhu, I. D. Mascanfroni, Z. Al Adham, S. Lavoie, M. Ibourk, D. D. Nguyen, J. N. Samsom, J. C. Escher, R. Somech, B. Weiss, R. Beier, L. S. Conklin, C. L. Ebens, F. G. Santos, A. R. Ferreira, M. Sherlock, A. K. Bhan, W. Müller, J. R. Mora, F. J. Quintana, C. Klein, A. M. Muise, B. H. Horwitz, S. B. Snapper, Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function. Immunity 40, 706–719 (2014).
16. E. Zigmond, B. Bernshtein, G. Friedlander, C. R. Walker, S. Yona, K.-W. Kim, O. Brenner, R. Krauthgamer, C. Varol, W. Müller, S. Jung, Macrophage-restricted interleukin-10 receptor deficiency, but not IL-10 deficiency, causes severe spontaneous colitis. Immunity 40, 720–733 (2014).
17. W. K. E. Ip, N. Hoshi, D. S. Shouval, S. Snapper, R. Medzhitov, Anti-inflammatory effect of IL-10 mediated by metabolic reprogramming of macrophages. Science 356, 513–519 (2017).
18. D. M. Willerford, J. Chen, J. A. Ferry, L. Davidson, A. Ma, F. W. Alt, Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity 3, 521–530 (1995).
19. A. Ma, M. Datta, E. Margosian, J. Chen, I. Horak, T cells, but not B cells, are required for bowel inflammation in interleukin 2-deficient mice. J. Exp. Med. 182, 1567–1572 (1995).
20. O. Boyman, J. Sprent, The role of interleukin-2 during homeostasis and activation of the immune system. Nat. Rev. Immunol. 12, 180–190 (2012).
21. S. Z. Josefowicz, L. F. Lu, A. Y. Rudensky, Regulatory T cells: Mechanisms of differentiation and function. Annu. Rev. Immunol. 30, 531–564 (2012).
22. T. Chinen, A. K. Kannan, A. G. Levine, X. Fan, U. Klein, Y. Zheng, G. Gasteiger, Y. Feng, J. D. Fontenot, A. Y. Rudensky, An essential role for the IL-2 receptor in Treg cell function. Nat. Immunol. 17, 1322–1333 (2016).
23. J. Loschko, H. A. Schreiber, G. J. Rieke, D. Esterházy, M. M. Meredith, V. A. Pedicord, K.-H. Yao, S. Caballero, E. G. Pamer, D. Mucida, M. C. Nussenzweig, Absence of MHC class II on cDCs results in microbial-dependent intestinal inflammation. J. Exp. Med. 213, 517–534 (2016).
24. K. L. Madsen, J. S. Doyle, M. M. Tavernini, L. D. Jewell, R. P. Rennie, R. N. Fedorak, Antibiotic therapy attenuates colitis in interleukin 10 gene-deficient mice. Gastroenterology 118, 1094–1105 (2000).
25. R. K. Sellon, S. Tonkonogy, M. Schultz, L. A. Dieleman, W. Grenther, E. Balish, D. M. Rennick, R. B. Sartor, Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect. Immun. 66, 5224–5231 (1998).
26. L. A. Dieleman, A. Arends, S. L. Tonkonogy, M. S. Goerres, D. W. Craft, W. Grenther, R. K. Sellon, E. Balish, R. B. Sartor, Helicobacter hepaticus does not induce or potentiate colitis in interleukin-10-deficient mice. Infect. Immun. 68, 5107–5113 (2000).
27. K. L. Madsen, J. S. Doyle, L. D. Jewell, M. M. Tavernini, R. N. Fedorak, Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice. Gastroenterology 116, 1107–1114 (1999).
28. K. Madsen, A. Cornish, P. Soper, C. McKaigney, H. Jijon, C. Yachimec, J. Doyle, L. Jewell, C. De Simone, Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121, 580–591 (2001).
29. L. Dianda, A. M. Hanby, N. A. Wright, A. Sebesteny, A. C. Hayday, M. J. Owen, T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment. Am. J. Pathol. 150, 91–97 (1997).
30. M. Schultz, S. L. Tonkonogy, R. K. Sellon, C. Veltkamp, V. L. Godfrey, J. Kwon, W. B. Grenther, E. Balish, I. Horak, R. B. Sartor, IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation. Am. J. Physiol. 276, G1461–G1472 (1999).
31. M. Schuppler, K. Lotzsch, M. Waidmann, I. B. Autenrieth, An abundance of Escherichia coli is harbored by the mucosa-associated bacterial flora of interleukin-2-deficient mice. Infect. Immun. 72, 1983–1990 (2004).
32. M. Waidmann, O. Bechtold, J. S. Frick, H.-A. Lehr, S. Schubert, U. Dobrindt, J. Loeffler, E. Bohn, I. B. Autenrieth, Bacteroides vulgatus protects against Escherichia coli-induced colitis in gnotobiotic interleukin-2-deficient mice. Gastroenterology 125, 162–177 (2003).
33. Y. Goto, C. Panea, G. Nakato, A. Cebula, C. Lee, M. G. Diez, T. M. Laufer, L. Ignatowicz, I. I. Ivanov, Segmented filamentous bacteria antigens presented by intestinal dendritic cells drive mucosal Th17 cell differentiation. Immunity 40, 594–607 (2014).
34. I. I. Ivanov, K. Atarashi, N. Manel, E. L. Brodie, T. Shima, U. Karaoz, D. Wei, K. C. Goldfarb, C. A. Santee, S. V. Lynch, T. Tanoue, A. Imaoka, K. Itoh, K. Takeda, Y. Umesaki, K. Honda, D. R. Littman, Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell 139, 485–498 (2009).
35. T. Sano, W. Huang, J. A. Hall, Y. Yang, A. Chen, S. J. Gavzy, J.-Y. Lee, J. W. Ziel, E. R. Miraldi, A. I. Domingos, R. Bonneau, D. R. Littman, An IL-23R/IL-22 circuit regulates epithelial serum amyloid A to promote local effector Th17 responses. Cell 163, 381–393 (2015).
36. K. Atarashi, T. Tanoue, M. Ando, N. Kamada, Y. Nagano, S. Narushima, W. Suda, A. Imaoka, H. Setoyama, T. Nagamori, E. Ishikawa, T. Shima, T. Hara, S. Kado, T. Jinnohara, H. Ohno, T. Kondo, K. Toyooka, E. Watanabe, S.-I. Yokoyama, S. Tokoro, H. Mori, Y. Noguchi, H. Morita, I. I. Ivanov, T. Sugiyama, G. Nuñez, J. G. Camp, M. Hattori, Y. Umesaki, K. Honda, Th17 cell induction by adhesion of microbes to intestinal epithelial cells. Cell 163, 367–380 (2015).
37. K. Atarashi, T. Tanoue, K. Oshima, W. Suda, Y. Nagano, H. Nishikawa, S. Fukuda, T. Saito, S. Narushima, K. Hase, S. Kim, J. V. Fritz, P. Wilmes, S. Ueha, K. Matsushima, H. Ohno, B. Olle, S. Sakaguchi, T. Taniguchi, H. Morita, M. Hattori, K. Honda, Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 500, 232–236 (2013).
38. K. Atarashi, T. Tanoue, T. Shima, A. Imaoka, T. Kuwahara, Y. Momose, G. Cheng, S. Yamasaki, T. Saito, Y. Ohba, T. Taniguchi, K. Takeda, S. Hori, I. I. Ivanov, Y. Umesaki, K. Itoh, K. Honda, Induction of colonic regulatory T cells by indigenous Clostridium species. Science 331, 337–341 (2011).
39. J. L. Round, S. M. Lee, J. Li, G. Tran, B. Jabri, T. A. Chatila, S. K. Mazmanian, The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota. Science 332, 974–977 (2011).
40. N. Arpaia, C. Campbell, X. Fan, S. Dikiy, J. van der Veeken, P. deRoos, H. Liu, J. R. Cross, K. Pfeffer, P. J. Coffer, A. Y. Rudensky, Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature 504, 451–455 (2013).
41. Y. Furusawa, Y. Obata, S. Fukuda, T. A. Endo, G. Nakato, D. Takahashi, Y. Nakanishi, C. Uetake, K. Kato, T. Kato, M. Takahashi, N. N. Fukuda, S. Murakami, E. Miyauchi, S. Hino, K. Atarashi, S. Onawa, Y. Fujimura, T. Lockett, J. M. Clarke, D. L. Topping, M. Tomita, S. Hori, O. Ohara, T. Morita, H. Koseki, J. Kikuchi, K. Honda, K. Hase, H. Ohno, Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature 504, 446–450 (2013).
42. P. M. Smith, M. R. Howitt, N. Panikov, M. Michaud, C. A. Gallini, M. Bohlooly-Y, J. N. Glickman, W. S. Garrett, The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 341, 569–573 (2013).
43. W. S. Garrett, G. M. Lord, S. Punit, G. Lugo-Villarino, S. K. Mazmanian, S. Ito, J. N. Glickman, L. H. Glimcher, Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 131, 33–45 (2007).
44. + innate lymphoid cells. Immunity 37, 674–684 (2012).
45. E. Elinav, T. Strowig, A. L. Kau, J. Henao-Mejia, C. A. Thaiss, C. J. Booth, D. R. Peaper, J. Bertin, S. C. Eisenbarth, J. I. Gordon, R. A. Flavell, NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145, 745–757 (2011).
46. M. Mamantopoulos, F. Ronchi, F. Van Hauwermeiren, S. Vieira-Silva, B. Yilmaz, L. Martens, Y. Saeys, S. K. Drexler, A. S. Yazdi, J. Raes, M. Lamkanfi, K. D. McCoy, A. Wullaert, Nlrp6- and ASC-dependent inflammasomes do not shape the commensal gut microbiota composition. Immunity 47, 339–348.e4 (2017).
47. G. F. Sonnenberg, L. A. Fouser, D. Artis, Border patrol: Regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat. Immunol. 12, 383–390 (2011).
48. G. F. Sonnenberg, L. A. Monticelli, T. Alenghat, T. C. Fung, N. A. Hutnick, J. Kunisawa, N. Shibata, S. Grunberg, R. Sinha, A. M. Zahm, M. R. Tardif, T. Sathaliyawala, M. Kubota, D. L. Farber, R. G. Collman, A. Shaked, L. A. Fouser, D. B. Weiner, P. A. Tessier, J. R. Friedman, H. Kiyono, F. D. Bushman, K.-M. Chang, D. Artis, Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science 336, 1321–1325 (2012).
49. Y. Zheng, P. A. Valdez, D. M. Danilenko, Y. Hu, S. M. Sa, Q. Gong, A. R. Abbas, Z. Modrusan, N. Ghilardi, F. J. de Sauvage, W. Ouyang, Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 14, 282–289 (2008).
50. Y. Goto, T. Obata, J. Kunisawa, S. Sato, I. I. Ivanov, A. Lamichhane, N. Takeyama, M. Kamioka, M. Sakamoto, T. Matsuki, H. Setoyama, A. Imaoka, S. Uematsu, S. Akira, S. E. Domino, P. Kulig, B. Becher, J.-C. Renauld, C. Sasakawa, Y. Umesaki, Y. Benno, H. Kiyono, Innate lymphoid cells regulate intestinal epithelial cell glycosylation. Science 345, 1254009 (2014).
51. T. A. Pham, S. Clare, D. Goulding, J. M. Arasteh, M. D. Stares, H. P. Browne, J. A. Keane, A. J. Page, N. Kumasaka, L. Kane, L. Mottram, K. Harcourt, C. Hale, M. J. Arends; Sanger Mouse Genetics Project, G. Dougan, T. D. Lawley, Epithelial IL-22RA1-mediated fucosylation promotes intestinal colonization resistance to an opportunistic pathogen. Cell Host Microbe 16, 504–516 (2014).
52. J. M. Pickard, C. F. Maurice, M. A. Kinnebrew, M. C. Abt, D. Schenten, T. V. Golovkina, S. R. Bogatyrev, R. F. Ismagilov, E. G. Pamer, P. J. Turnbaugh, A. V. Chervonsky, Rapid fucosylation of intestinal epithelium sustains host-commensal symbiosis in sickness. Nature 514, 638–641 (2014).
53. H. Spits, D. Artis, M. Colonna, A. Diefenbach, J. P. Di Santo, G. Eberl, S. Koyasu, R. M. Locksley, A. N. J. McKenzie, R. E. Mebius, F. Powrie, E. Vivier, Innate lymphoid cells—A proposal for uniform nomenclature. Nat. Rev. Immunol. 13, 145–149 (2013).
54. G. F. Sonnenberg, D. Artis, Innate lymphoid cell interactions with microbiota: Implications for intestinal health and disease. Immunity 37, 601–610 (2012).
55. A. Mortha, A. Chudnovskiy, D. Hashimoto, M. Bogunovic, S. P. Spencer, Y. Belkaid, M. Merad, Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis. Science 343, 1249288 (2014).
56. T. C. Fung, N. J. Bessman, M. R. Hepworth, N. Kumar, N. Shibata, D. Kobuley, K. Wang, C. G. K. Ziegler, J. Goc, T. Shima, Y. Umesaki, R. B. Sartor, K. V. Sullivan, T. D. Lawley, J. Kunisawa, H. Kiyono, G. F. Sonnenberg, Lymphoid-tissue-resident commensal bacteria promote members of the IL-10 cytokine family to establish mutualism. Immunity 44, 634–646 (2016).
57. + lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity 34, 122–134 (2011).
58. M. Tsuji, K. Suzuki, H. Kitamura, M. Maruya, K. Kinoshita, I. I. Ivanov, K. Itoh, D. R. Littman, S. Fagarasan, Requirement for lymphoid tissue-inducer cells in isolated follicle formation and T cell-independent immunoglobulin A generation in the gut. Immunity 29, 261–271 (2008).
59. + T-cell responses to intestinal commensal bacteria. Nature 498, 113–117 (2013).
60. + T cells. Science 348, 1031–1035 (2015).
61. B. Khor, A. Gardet, R. J. Xavier, Genetics and pathogenesis of inflammatory bowel disease. Nature 474, 307–317 (2011).
62. L. Jostins, S. Ripke, R. K. Weersma, R. H. Duerr, D. P. McGovern, K. Y. Hui, J. C. Lee, L. P. Schumm, Y. Sharma, C. A. Anderson, J. Essers, M. Mitrovic, K. Ning, I. Cleynen, E. Theatre, S. L. Spain, S. Raychaudhuri, P. Goyette, Z. Wei, C. Abraham, J.-P. Achkar, T. Ahmad, L. Amininejad, A. N. Ananthakrishnan, V. Andersen, J. M. Andrews, L. Baidoo, T. Balschun, P. A. Bampton, A. Bitton, G. Boucher, S. Brand, C. Büning, A. Cohain, S. Cichon, M. D’Amato, D. De Jong, K. L. Devaney, M. Dubinsky, C. Edwards, D. Ellinghaus, L. R. Ferguson, D. Franchimont, K. Fransen, R. Gearry, M. Georges, C. Gieger, J. Glas, T. Haritunians, A. Hart, C. Hawkey, M. Hedl, X. Hu, T. H. Karlsen, L. Kupcinskas, S. Kugathasan, A. Latiano, D. Laukens, I. C. Lawrance, C. W. Lees, E. Louis, G. Mahy, J. Mansfield, A. R. Morgan, C. Mowat, W. Newman, O. Palmieri, C. Y. Ponsioen, U. Potocnik, N. J. Prescott, M. Regueiro, J. I. Rotter, R. K. Russell, J. D. Sanderson, M. Sans, J. Satsangi, S. Schreiber, L. A. Simms, J. Sventoraityte, S. R. Targan, K. D. Taylor, M. Tremelling, H. W. Verspaget, M. De Vos, C. Wijmenga, D. C. Wilson, J. Winkelmann, R. J. Xavier, S. Zeissig, B. Zhang, C. K. Zhang, H. Zhao; International IBD Genetics Consortium (IIBDGC), M. S. Silverberg, V. Annese, H. Hakonarson, S. R. Brant, G. Radford-Smith, C. G. Mathew, J. D. Rioux, E. E. Schadt, M. J. Daly, A. Franke, M. Parkes, S. Vermeire, J. C. Barrett, J. H. Cho, Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119–124 (2012).
63. E.-O. Glocker, D. Kotlarz, K. Boztug, E. M. Gertz, A. A. Schäffer, F. Noyan, M. Perro, J. Diestelhorst, A. Allroth, D. Murugan, N. Hätscher, D. Pfeifer, K. W. Sykora, M. Sauer, H. Kreipe, M. Lacher, R. Nustede, C. Woellner, U. Baumann, U. Salzer, S. Koletzko, N. Shah, A. W. Segal, A. Sauerbrey, S. Buderus, S. B. Snapper, B. Grimbacher, C. Klein, Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. N. Engl. J. Med. 361, 2033–2045 (2009).
64. N. Sharfe, H. K. Dadi, M. Shahar, C. M. Roifman, Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor. Proc. Natl. Acad. Sci. U.S.A. 94, 3168–3171 (1997).
65. E. I. Benchimol, D. R. Mack, G. C. Nguyen, S. B. Snapper, W. Li, N. Mojaverian, P. Quach, A. M. Muise, Incidence, outcomes, and health services burden of very early onset inflammatory bowel disease. Gastroenterology 147, 803–813.e7 (2014).
66. A. Geremia, C. V. Arancibia-Cárcamo, M. P. P. Fleming, N. Rust, B. Singh, N. J. Mortensen, S. P. L. Travis, F. Powrie, IL-23–responsive innate lymphoid cells are increased in inflammatory bowel disease. J. Exp. Med. 208, 1127–1133 (2011).
67. + mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. J. Exp. Med. 211, 1571–1583 (2014).
68. J. H. Bernink, C. P. Peters, M. Munneke, A. A. te Velde, S. L. Meijer, K. Weijer, H. S. Hreggvidsdottir, S. E. Heinsbroek, N. Legrand, C. J. Buskens, W. A. Bemelman, J. M. Mjösberg, H. Spits, Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat. Immunol. 14, 221–229 (2013).
69. M. F. Neurath, Current and emerging therapeutic targets for IBD. Nat. Rev. Gastroenterol. Hepatol. 14, 269–278 (2017).
70. W. Hueber, B. E. Sands, S. Lewitzky, M. Vandemeulebroecke, W. Reinisch, P. D. R. Higgins, J. Wehkamp, B. G. Feagan, M. D. Yao, M. Karczewski, J. Karczewski, N. Pezous, S. Bek, G. Bruin, B. Mellgard, C. Berger, M. Londei, A. P. Bertolino, G. Tougas, S. P. Travis; Secukinumab in Crohn’s Disease Study Group, Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn’s disease: Unexpected results of a randomised, double-blind placebo-controlled trial. Gut 61, 1693–1700 (2012).
71. J. S. Lee, C. M. Tato, B. Joyce-Shaikh, M. F. Gulen, C. Cayatte, Y. Chen, W. M. Blumenschein, M. Judo, G. Ayanoglu, T. K. McClanahan, X. Li, D. J. Cua, Interleukin-23-independent IL-17 production regulates intestinal epithelial permeability. Immunity 43, 727–738 (2015).
72. D. R. Withers, M. R. Hepworth, X. Wang, E. C. Mackley, E. E. Halford, E. E. Dutton, C. L. Marriott, V. Brucklacher-Waldert, M. Veldhoen, J. Kelsen, R. N. Baldassano, G. F. Sonnenberg, Transient inhibition of ROR-t therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells. Nat. Med. 22, 319–323 (2016).
73. D. Klatzmann, A. K. Abbas, The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases. Nat. Rev. Immunol. 15, 283–294 (2015).